Form 4 for CNMD CONMED Corp
Accepted 2022-03-07 00:00:00 ET · period of report 2022-03-03 · accession 0001127602-22-008445 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-07 | 2022-03-03 | CNMD | KENNEDY JOHN JED | Group EVP | M - OptEx | $68.39 | +7,714 | 10.7K | +259% | +$527.6K |
| DM | 2022-03-07 | 2022-03-03 | CNMD | KENNEDY JOHN JED | Group EVP | S - Sale+OE | $144.27 | -7,714 | 9,855 | -44% | -$1.11M |
| DM | 2022-03-07 | 2022-03-03 | CNMD | KENNEDY JOHN JED | Group EVP | M - OptEx | $0.00 | -7,714 | 6,768 | -53% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-03 | M | A | 1,790 | $78.76 | 11,645 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-03 | S | D | 5,092 | $144.25 | 9,855 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.25 to $144.36. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 3 | Common | Common Stock | 2022-03-03 | M | A | 5,092 | $59.96 | 14,947 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-03 | M | A | 832 | $97.69 | 10,687 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-03 | S | D | 1,790 | $144.32 | 9,855 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.50. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 6 | Common | Common Stock | 2022-03-03 | S | D | 832 | $144.33 | 9,855 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.26 to $144.40. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. |
| 7 | Derivative | Options To Purchase Common Stock | 2022-03-03 | M | D | 1,790 | $0.00 | 3,800 | D | $78.76 · — to 2029-03-01 | 1,790 Common Stock | (F5) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| 8 | Derivative | Options To Purchase Common Stock | 2022-03-03 | M | D | 5,092 | $0.00 | 5,400 | D | $59.96 · — to 2028-03-01 | 5,092 Common Stock | (F4) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. |
| 9 | Derivative | Options To Purchase Common Stock | 2022-03-03 | M | D | 832 | $0.00 | 6,768 | D | $97.69 · — to 2030-03-02 | 832 Common Stock | (F5) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period |